The role of islet autoantibody status in the association between HLA markers and the risk of type 1 diabetes in children
Open Access
- 5 July 2026
- journal article
- Published by ECO-Vector LLC (Publications) in Russian Medicine
- Vol. 32 (3) , 230-238
Abstract
BACKGROUND: Despite the leading role of HLA markers in genetic susceptibility to type 1 diabetes (T1D), their prognostic value for individual risk assessment remains limited. The role of autoantibody status as a mediating or independent factor in the association between HLA markers and the risk of T1D in children is still insufficiently studied. AIM:To evaluate the role of islet autoantibody status as a mediating factor in the association between HLA markers and the risk of T1Din children. METHODS:The study included 423 participants: 257 patients aged 0–17 years with newly diagnosed T1D and 166 of their healthy biological siblings. The median age in both groups was 8 years, and males accounted for 58% of participants. All individuals were tested for islet autoantibodies (GADA, IA-2A, IAA, ZnT8A, ICA) and underwent HLA genotyping of HLA-A, -B, -C, -DR, -DQ, and -DP alleles. Blood samples were collected within 1–2 days of hospital admission in patients with T1D and on an outpatient basis in healthy siblings. RESULTS:Patients with T1D exhibited a higher frequency and higher levels of islet autoantibodies, particularly ZnT8A, IA-2A, and GADA. Classical high-risk haplotypes DR3–DQ2 and DR4–DQ8 predominated in the T1D group. The HLA-B*08:01 allele and the DRB1*08:01–DQA1*04:01–DQB1*04:02 haplotype were more common in patients with T1D, whereas the DPB1*04:02 allele was characteristic of healthy siblings. Multivariable models demonstrated that some HLA markers were associated with T1D risk independently of autoantibody status, while other effects were predominantly mediated by autoimmune activity. CONCLUSION:The combined assessment of HLA genetic markers and autoantibody status provides a more comprehensive characterization of preclinical immunogenetic pathways involved in the development of T1D in children and may improve the effectiveness of early screening.Keywords
This publication has 13 references indexed in Scilit:
- HLA-focused type 1 diabetes genetic risk prediction in populations of diverse ancestryDiabetologia, 2025
- The heterogeneity of type 1 diabetes: implications for pathogenesis, prevention, and treatment—2024 Diabetes, Diabetes Care, and Diabetologia Expert ForumDiabetologia, 2025
- Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: Results from the International diabetes Federation Atlas, 11th Edition, and the T1D Index Version 3.0Diabetes Research and Clinical Practice, 2025
- IA-2A positivity increases risk of progression within and across established stages of type 1 diabetesDiabetologia, 2025
- Genetic Discovery and Risk Prediction for Type 1 Diabetes in Individuals Without High-Risk HLA-DR3/DR4 HaplotypesDiabetes Care, 2024
- Allelic variants of genes of the main histocompatibility complex in children with type 1 diabetes mellitus who became ill at preschool ageDiabetes mellitus, 2024
- Islet autoantibodies as precision diagnostic tools to characterize heterogeneity in type 1 diabetes: a systematic reviewCommunications Medicine, 2024
- The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetesDiabetologia, 2022
- Immunogenomics of Killer Cell Immunoglobulin-Like Receptor (KIR) and HLA Class I: Coevolution and Consequences for Human HealthThe Journal of Allergy and Clinical Immunology: In Practice, 2022
- Type 1 diabetes—early life origins and changing epidemiologyThe Lancet Diabetes & Endocrinology, 2020